Multicenter, randomized, double-blind, double-dummy, active-comparator, event-driven, superiority phase III study of secondary prevention of stroke and revention of systemic embolism in patients with a recent Embolic Stroke of Undetermined Source (ESUS)
|Effective start/end date||12/15/14 → 12/15/17|
- BAYER HEALTHCARE PHARMACEUTICALS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.